Any claim that a peptide affects cognition implies a claim that it reaches the brain. That second claim is rarely tested and frequently assumed.
Key Takeaways
- The barrier is formed by tight-junction-sealed endothelium supported by pericytes and astrocytes.
- Passive entry favors small, lipophilic, uncharged molecules — the opposite of most peptides.
- Active efflux transporters remove many compounds that do diffuse in.
- Specific carrier and receptor-mediated systems transport a limited set of peptides.
- CNS penetration must be measured, not inferred from a behavioral result.
What the Barrier Actually Is
Brain capillary endothelial cells are joined by continuous tight junctions containing claudins and occludin, eliminating the paracellular gaps found in peripheral capillaries. Pericytes wrap the vessel, astrocyte end-feet cover most of the abluminal surface, and the whole assembly is described as the neurovascular unit. Transcytosis rates are low and the endothelium expresses high levels of metabolic enzymes.
The practical consequence: the default state for a hydrophilic peptide is exclusion.
Routes Across
| Route | Mechanism | Typical substrates |
|---|---|---|
| Passive transcellular diffusion | Lipid partitioning | Small lipophilic molecules |
| Carrier-mediated transport | Solute carrier proteins | Glucose, amino acids, some small peptides |
| Receptor-mediated transcytosis | Vesicular transport | Insulin, transferrin, IGF-1 |
| Adsorptive transcytosis | Charge interaction | Cationic peptides, some cell-penetrating sequences |
| Efflux transport (outward) | ABC transporters such as P-gp | Many xenobiotics, some peptides |
| Circumventricular organs | Regionally fenestrated capillaries | Peripheral hormone sensing |
Circumventricular organs deserve special mention: the area postrema and median eminence have partially permeable vasculature, which is how peripherally administered hormones influence central circuits without crossing the barrier proper. Several metabolic peptides act this way, as discussed in our appetite regulation article.
Measuring Penetration
- Brain-to-plasma ratio with corrections for residual vascular volume.
- In situ brain perfusion, which isolates transport from systemic pharmacokinetics.
- Radiolabel or LC-MS/MS quantification of intact compound, not just total radioactivity — a degraded fragment counts as signal in poorly designed studies.
- Cerebrospinal fluid sampling, which reflects a different barrier and does not equal parenchymal exposure.
- In vitro barrier models using co-cultured endothelium; useful for ranking, weak for absolute prediction.
The most common error in the literature is treating a behavioral change in a rodent as proof of central entry. Peripheral signaling, vagal afferents, and stress responses can all produce behavioral change without a molecule ever crossing.
Strategies Researchers Use
Modification approaches include increasing lipophilicity, N-methylation to resist proteases, cyclization, conjugation to a transferrin or insulin receptor ligand, and intranasal delivery routes that partially bypass the barrier via olfactory and trigeminal pathways. Each carries trade-offs in stability, target affinity, and off-target distribution.
Reading Neuro Claims Carefully
- Does the paper report measured brain concentrations, or only an effect?
- Was intact compound quantified, or total label?
- Was the route of administration one that could plausibly deliver to the CNS?
- Are the effective concentrations in vitro achievable in brain tissue in vivo?
Our guide to common literature misreadings covers this class of inference error in general terms.
What Is Not Established
Central nervous system penetration data for most research peptides is limited, inconsistent, or absent. Nothing in this literature establishes human safety or cognitive efficacy for research-grade materials.
Related Research Materials
Third-party lab tested Semax, Selank, and Dihexa are available with COAs for laboratory research use only.
References
- Banks WA. From blood-brain barrier to blood-brain interface. Nat Rev Drug Discov.
- Abbott NJ, et al. Structure and function of the blood-brain barrier. Neurobiol Dis.
- Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab.
Amino Fuel Labs products are sold strictly for laboratory research use only. They are not intended for human or veterinary use, consumption, diagnosis, treatment, cure, or prevention of disease. This article is educational and is not medical advice.
